HeatMate successfully developed a temperature-controlled refrigerant for the COVID-19 vaccine.
2020-11-02

The outbreak of the COVID-19 pandemic has caused tremendous economic and life property losses worldwide. The control of the COVID-19 pandemic globally can only rely on the development and widespread use of vaccines.

Currently, the temperature requirements for COVID-19 vaccines developed by global pharmaceutical companies are generally -20℃ to -80℃, which is much lower than the standard temperature of 2℃ to 8℃ for most medicines during transportation. According to the Associated Press, the entire process from the production of these COVID-19 vaccines in factories to being pushed into syringes must be carried out continuously in a sterile environment within this temperature range. How to achieve global transportation of COVID-19 vaccines in the near future has also become a major challenge. Once a vaccine is developed, the cold chain transportation of COVID-19 vaccines should be at the pinnacle of the cold chain industry pyramid to facilitate rapid vaccination globally.

Regarding the public's concern about the cold chain transportation of COVID-19 vaccines, Hema New Energy (HM) has successfully developed various mature and efficient phase change refrigerants, especially the ultra-low temperature phase change refrigerants at -70℃ to -80℃.
The three main temperature ranges for the cold chain transportation of COVID-19 vaccines and the refrigerants provided by Hema:
1. 2-8℃: HM-O5
2. -20℃: HM-E-24, HM-E-25
3. -70℃ to -80℃: HM-EO-57, HM-EO-75, HM-EO-80

Hema refrigerants will be on standby at all times to assist in delivering COVID-19 vaccines to various parts of the world, completing this 'century mission'!
Hema - a stable and efficient partner for biological safety products!
About Hema New Energy
Hema New Energy Technology (Shanghai) Co., Ltd. is a high-tech enterprise dedicated to the research, development, production, and sales of efficient phase change energy storage materials, products, and overall solutions. The company holds more than 50 intellectual property rights, including over 20 invention patents, and is also a participating unit in national and industry standards such as 'Thermal Storage Electric Heating Devices', 'Technical Guidelines for Industrial Low-Grade Waste Heat Central Heating Systems', 'Phase Change Thermal Storage Devices', 'Clean Energy Heating Technical Regulations', 'Green Building Materials Evaluation Standards - Energy Storage Devices for Buildings', and 'Testing Methods for the Lifespan of Inorganic Hydrated Salt Phase Change Materials', and has participated in the compilation of the 'Design Specifications for Electric Heating Boiler Rooms' in Xinjiang.
The phase change thermal storage materials independently developed by Hema New Energy Technology have passed tests for corrosiveness, 9000 cycles of high and low temperature stability, RoHS, skin irritation, and oral toxicity. The company's core products are phase change energy storage components and thermal pools.
Phase change energy storage materials, storage components, and thermal pools are widely used in clean heating and cooling, waste heat utilization, cold storage cold chain, electronic device temperature control, green building materials, and home appliances.
Hema New Energy has over 200 clean heating projects operating in Northwest, North China, Northeast, Central China, and East China, consuming about 70 million kWh of valley electricity each year, reducing carbon dioxide by about 100,000 tons, sulfur dioxide by about 280 tons, nitrogen oxides by about 260 tons, and smoke dust by about 6,600 tons.
Palabras clave:
Noticias relacionadas
2024-06-12
Academician Shi Zhengrong won the “Global Solar Leader" award!
2024-05-22
HeatMate New Energy debuted at the first phase change materials innovation and application forum
2024-05-22